Global Wet Age-Related Macular Degeneration Treatment Supply, Demand and Key Producers, 2024-2030

Description

The global Wet Age-Related Macular Degeneration Treatment market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The most common treatment doctors use to slow vision loss from wet AMD is called anti-VEGF injections. These medicines help stop bleeding and leaking from blood vessels in the back of your eye. Most people with wet AMD will get anti-VEGF injections as their only treatment.

This report studies the global Wet Age-Related Macular Degeneration Treatment production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Wet Age-Related Macular Degeneration Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Wet Age-Related Macular Degeneration Treatment that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Wet Age-Related Macular Degeneration Treatment total production and demand, 2019-2030, (K Units)
Global Wet Age-Related Macular Degeneration Treatment total production value, 2019-2030, (USD Million)
Global Wet Age-Related Macular Degeneration Treatment production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Wet Age-Related Macular Degeneration Treatment consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Wet Age-Related Macular Degeneration Treatment domestic production, consumption, key domestic manufacturers and share
Global Wet Age-Related Macular Degeneration Treatment production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Wet Age-Related Macular Degeneration Treatment production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Wet Age-Related Macular Degeneration Treatment production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Wet Age-Related Macular Degeneration Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Regeneron Pharmaceuticals, Bayer HealthCare and Kanghong Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Wet Age-Related Macular Degeneration Treatment market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Wet Age-Related Macular Degeneration Treatment Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Wet Age-Related Macular Degeneration Treatment Market, Segmentation by Type
    Lucentis
    Eylea
    Avastin
    Others

Global Wet Age-Related Macular Degeneration Treatment Market, Segmentation by Application
    Hospital
    Clinic
    Other

Companies Profiled:
    Roche
    Novartis
    Regeneron Pharmaceuticals
    Bayer HealthCare
    Kanghong Pharma

Key Questions Answered
1. How big is the global Wet Age-Related Macular Degeneration Treatment market?
2. What is the demand of the global Wet Age-Related Macular Degeneration Treatment market?
3. What is the year over year growth of the global Wet Age-Related Macular Degeneration Treatment market?
4. What is the production and production value of the global Wet Age-Related Macular Degeneration Treatment market?
5. Who are the key producers in the global Wet Age-Related Macular Degeneration Treatment market?

Table of Contents

1 Supply Summary
    1.1 Wet Age-Related Macular Degeneration Treatment Introduction
    1.2 World Wet Age-Related Macular Degeneration Treatment Supply & Forecast
        1.2.1 World Wet Age-Related Macular Degeneration Treatment Production Value (2019 & 2023 & 2030)
        1.2.2 World Wet Age-Related Macular Degeneration Treatment Production (2019-2030)
        1.2.3 World Wet Age-Related Macular Degeneration Treatment Pricing Trends (2019-2030)
    1.3 World Wet Age-Related Macular Degeneration Treatment Production by Region (Based on Production Site)
        1.3.1 World Wet Age-Related Macular Degeneration Treatment Production Value by Region (2019-2030)
        1.3.2 World Wet Age-Related Macular Degeneration Treatment Production by Region (2019-2030)
        1.3.3 World Wet Age-Related Macular Degeneration Treatment Average Price by Region (2019-2030)
        1.3.4 North America Wet Age-Related Macular Degeneration Treatment Production (2019-2030)
        1.3.5 Europe Wet Age-Related Macular Degeneration Treatment Production (2019-2030)
        1.3.6 China Wet Age-Related Macular Degeneration Treatment Production (2019-2030)
        1.3.7 Japan Wet Age-Related Macular Degeneration Treatment Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Wet Age-Related Macular Degeneration Treatment Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Wet Age-Related Macular Degeneration Treatment Major Market Trends

2 Demand Summary
    2.1 World Wet Age-Related Macular Degeneration Treatment Demand (2019-2030)
    2.2 World Wet Age-Related Macular Degeneration Treatment Consumption by Region
        2.2.1 World Wet Age-Related Macular Degeneration Treatment Consumption by Region (2019-2024)
        2.2.2 World Wet Age-Related Macular Degeneration Treatment Consumption Forecast by Region (2025-2030)
    2.3 United States Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030)
    2.4 China Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030)
    2.5 Europe Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030)
    2.6 Japan Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030)
    2.7 South Korea Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030)
    2.8 ASEAN Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030)
    2.9 India Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030)

3 World Wet Age-Related Macular Degeneration Treatment Manufacturers Competitive Analysis
    3.1 World Wet Age-Related Macular Degeneration Treatment Production Value by Manufacturer (2019-2024)
    3.2 World Wet Age-Related Macular Degeneration Treatment Production by Manufacturer (2019-2024)
    3.3 World Wet Age-Related Macular Degeneration Treatment Average Price by Manufacturer (2019-2024)
    3.4 Wet Age-Related Macular Degeneration Treatment Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Wet Age-Related Macular Degeneration Treatment Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Wet Age-Related Macular Degeneration Treatment in 2023
        3.5.3 Global Concentration Ratios (CR8) for Wet Age-Related Macular Degeneration Treatment in 2023
    3.6 Wet Age-Related Macular Degeneration Treatment Market: Overall Company Footprint Analysis
        3.6.1 Wet Age-Related Macular Degeneration Treatment Market: Region Footprint
        3.6.2 Wet Age-Related Macular Degeneration Treatment Market: Company Product Type Footprint
        3.6.3 Wet Age-Related Macular Degeneration Treatment Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Wet Age-Related Macular Degeneration Treatment Production Value Comparison
        4.1.1 United States VS China: Wet Age-Related Macular Degeneration Treatment Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Wet Age-Related Macular Degeneration Treatment Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Wet Age-Related Macular Degeneration Treatment Production Comparison
        4.2.1 United States VS China: Wet Age-Related Macular Degeneration Treatment Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Wet Age-Related Macular Degeneration Treatment Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Wet Age-Related Macular Degeneration Treatment Consumption Comparison
        4.3.1 United States VS China: Wet Age-Related Macular Degeneration Treatment Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Wet Age-Related Macular Degeneration Treatment Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Wet Age-Related Macular Degeneration Treatment Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Wet Age-Related Macular Degeneration Treatment Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production (2019-2024)
    4.5 China Based Wet Age-Related Macular Degeneration Treatment Manufacturers and Market Share
        4.5.1 China Based Wet Age-Related Macular Degeneration Treatment Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Value (2019-2024)
        4.5.3 China Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production (2019-2024)
    4.6 Rest of World Based Wet Age-Related Macular Degeneration Treatment Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Wet Age-Related Macular Degeneration Treatment Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production (2019-2024)

5 Market Analysis by Type
    5.1 World Wet Age-Related Macular Degeneration Treatment Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Lucentis
        5.2.2 Eylea
        5.2.3 Avastin
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Wet Age-Related Macular Degeneration Treatment Production by Type (2019-2030)
        5.3.2 World Wet Age-Related Macular Degeneration Treatment Production Value by Type (2019-2030)
        5.3.3 World Wet Age-Related Macular Degeneration Treatment Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Wet Age-Related Macular Degeneration Treatment Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Wet Age-Related Macular Degeneration Treatment Production by Application (2019-2030)
        6.3.2 World Wet Age-Related Macular Degeneration Treatment Production Value by Application (2019-2030)
        6.3.3 World Wet Age-Related Macular Degeneration Treatment Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Roche
        7.1.1 Roche Details
        7.1.2 Roche Major Business
        7.1.3 Roche Wet Age-Related Macular Degeneration Treatment Product and Services
        7.1.4 Roche Wet Age-Related Macular Degeneration Treatment Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Roche Recent Developments/Updates
        7.1.6 Roche Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Wet Age-Related Macular Degeneration Treatment Product and Services
        7.2.4 Novartis Wet Age-Related Macular Degeneration Treatment Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Regeneron Pharmaceuticals
        7.3.1 Regeneron Pharmaceuticals Details
        7.3.2 Regeneron Pharmaceuticals Major Business
        7.3.3 Regeneron Pharmaceuticals Wet Age-Related Macular Degeneration Treatment Product and Services
        7.3.4 Regeneron Pharmaceuticals Wet Age-Related Macular Degeneration Treatment Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Regeneron Pharmaceuticals Recent Developments/Updates
        7.3.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
    7.4 Bayer HealthCare
        7.4.1 Bayer HealthCare Details
        7.4.2 Bayer HealthCare Major Business
        7.4.3 Bayer HealthCare Wet Age-Related Macular Degeneration Treatment Product and Services
        7.4.4 Bayer HealthCare Wet Age-Related Macular Degeneration Treatment Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Bayer HealthCare Recent Developments/Updates
        7.4.6 Bayer HealthCare Competitive Strengths & Weaknesses
    7.5 Kanghong Pharma
        7.5.1 Kanghong Pharma Details
        7.5.2 Kanghong Pharma Major Business
        7.5.3 Kanghong Pharma Wet Age-Related Macular Degeneration Treatment Product and Services
        7.5.4 Kanghong Pharma Wet Age-Related Macular Degeneration Treatment Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Kanghong Pharma Recent Developments/Updates
        7.5.6 Kanghong Pharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Wet Age-Related Macular Degeneration Treatment Industry Chain
    8.2 Wet Age-Related Macular Degeneration Treatment Upstream Analysis
        8.2.1 Wet Age-Related Macular Degeneration Treatment Core Raw Materials
        8.2.2 Main Manufacturers of Wet Age-Related Macular Degeneration Treatment Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Wet Age-Related Macular Degeneration Treatment Production Mode
    8.6 Wet Age-Related Macular Degeneration Treatment Procurement Model
    8.7 Wet Age-Related Macular Degeneration Treatment Industry Sales Model and Sales Channels
        8.7.1 Wet Age-Related Macular Degeneration Treatment Sales Model
        8.7.2 Wet Age-Related Macular Degeneration Treatment Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Wet Age-Related Macular Degeneration Treatment Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Wet Age-Related Macular Degeneration Treatment Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Wet Age-Related Macular Degeneration Treatment Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Wet Age-Related Macular Degeneration Treatment Production Value Market Share by Region (2019-2024)
    Table 5. World Wet Age-Related Macular Degeneration Treatment Production Value Market Share by Region (2025-2030)
    Table 6. World Wet Age-Related Macular Degeneration Treatment Production by Region (2019-2024) & (K Units)
    Table 7. World Wet Age-Related Macular Degeneration Treatment Production by Region (2025-2030) & (K Units)
    Table 8. World Wet Age-Related Macular Degeneration Treatment Production Market Share by Region (2019-2024)
    Table 9. World Wet Age-Related Macular Degeneration Treatment Production Market Share by Region (2025-2030)
    Table 10. World Wet Age-Related Macular Degeneration Treatment Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Wet Age-Related Macular Degeneration Treatment Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Wet Age-Related Macular Degeneration Treatment Major Market Trends
    Table 13. World Wet Age-Related Macular Degeneration Treatment Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Wet Age-Related Macular Degeneration Treatment Consumption by Region (2019-2024) & (K Units)
    Table 15. World Wet Age-Related Macular Degeneration Treatment Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Wet Age-Related Macular Degeneration Treatment Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Wet Age-Related Macular Degeneration Treatment Producers in 2023
    Table 18. World Wet Age-Related Macular Degeneration Treatment Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Wet Age-Related Macular Degeneration Treatment Producers in 2023
    Table 20. World Wet Age-Related Macular Degeneration Treatment Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Wet Age-Related Macular Degeneration Treatment Company Evaluation Quadrant
    Table 22. World Wet Age-Related Macular Degeneration Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Wet Age-Related Macular Degeneration Treatment Production Site of Key Manufacturer
    Table 24. Wet Age-Related Macular Degeneration Treatment Market: Company Product Type Footprint
    Table 25. Wet Age-Related Macular Degeneration Treatment Market: Company Product Application Footprint
    Table 26. Wet Age-Related Macular Degeneration Treatment Competitive Factors
    Table 27. Wet Age-Related Macular Degeneration Treatment New Entrant and Capacity Expansion Plans
    Table 28. Wet Age-Related Macular Degeneration Treatment Mergers & Acquisitions Activity
    Table 29. United States VS China Wet Age-Related Macular Degeneration Treatment Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Wet Age-Related Macular Degeneration Treatment Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Wet Age-Related Macular Degeneration Treatment Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Wet Age-Related Macular Degeneration Treatment Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Market Share (2019-2024)
    Table 37. China Based Wet Age-Related Macular Degeneration Treatment Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Market Share (2019-2024)
    Table 42. Rest of World Based Wet Age-Related Macular Degeneration Treatment Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Market Share (2019-2024)
    Table 47. World Wet Age-Related Macular Degeneration Treatment Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Wet Age-Related Macular Degeneration Treatment Production by Type (2019-2024) & (K Units)
    Table 49. World Wet Age-Related Macular Degeneration Treatment Production by Type (2025-2030) & (K Units)
    Table 50. World Wet Age-Related Macular Degeneration Treatment Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Wet Age-Related Macular Degeneration Treatment Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Wet Age-Related Macular Degeneration Treatment Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Wet Age-Related Macular Degeneration Treatment Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Wet Age-Related Macular Degeneration Treatment Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Wet Age-Related Macular Degeneration Treatment Production by Application (2019-2024) & (K Units)
    Table 56. World Wet Age-Related Macular Degeneration Treatment Production by Application (2025-2030) & (K Units)
    Table 57. World Wet Age-Related Macular Degeneration Treatment Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Wet Age-Related Macular Degeneration Treatment Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Wet Age-Related Macular Degeneration Treatment Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Wet Age-Related Macular Degeneration Treatment Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Roche Basic Information, Manufacturing Base and Competitors
    Table 62. Roche Major Business
    Table 63. Roche Wet Age-Related Macular Degeneration Treatment Product and Services
    Table 64. Roche Wet Age-Related Macular Degeneration Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Roche Recent Developments/Updates
    Table 66. Roche Competitive Strengths & Weaknesses
    Table 67. Novartis Basic Information, Manufacturing Base and Competitors
    Table 68. Novartis Major Business
    Table 69. Novartis Wet Age-Related Macular Degeneration Treatment Product and Services
    Table 70. Novartis Wet Age-Related Macular Degeneration Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Novartis Recent Developments/Updates
    Table 72. Novartis Competitive Strengths & Weaknesses
    Table 73. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 74. Regeneron Pharmaceuticals Major Business
    Table 75. Regeneron Pharmaceuticals Wet Age-Related Macular Degeneration Treatment Product and Services
    Table 76. Regeneron Pharmaceuticals Wet Age-Related Macular Degeneration Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Regeneron Pharmaceuticals Recent Developments/Updates
    Table 78. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
    Table 79. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
    Table 80. Bayer HealthCare Major Business
    Table 81. Bayer HealthCare Wet Age-Related Macular Degeneration Treatment Product and Services
    Table 82. Bayer HealthCare Wet Age-Related Macular Degeneration Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Bayer HealthCare Recent Developments/Updates
    Table 84. Kanghong Pharma Basic Information, Manufacturing Base and Competitors
    Table 85. Kanghong Pharma Major Business
    Table 86. Kanghong Pharma Wet Age-Related Macular Degeneration Treatment Product and Services
    Table 87. Kanghong Pharma Wet Age-Related Macular Degeneration Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 88. Global Key Players of Wet Age-Related Macular Degeneration Treatment Upstream (Raw Materials)
    Table 89. Wet Age-Related Macular Degeneration Treatment Typical Customers
    Table 90. Wet Age-Related Macular Degeneration Treatment Typical Distributors
List of Figure
    Figure 1. Wet Age-Related Macular Degeneration Treatment Picture
    Figure 2. World Wet Age-Related Macular Degeneration Treatment Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Wet Age-Related Macular Degeneration Treatment Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Wet Age-Related Macular Degeneration Treatment Production (2019-2030) & (K Units)
    Figure 5. World Wet Age-Related Macular Degeneration Treatment Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Wet Age-Related Macular Degeneration Treatment Production Value Market Share by Region (2019-2030)
    Figure 7. World Wet Age-Related Macular Degeneration Treatment Production Market Share by Region (2019-2030)
    Figure 8. North America Wet Age-Related Macular Degeneration Treatment Production (2019-2030) & (K Units)
    Figure 9. Europe Wet Age-Related Macular Degeneration Treatment Production (2019-2030) & (K Units)
    Figure 10. China Wet Age-Related Macular Degeneration Treatment Production (2019-2030) & (K Units)
    Figure 11. Japan Wet Age-Related Macular Degeneration Treatment Production (2019-2030) & (K Units)
    Figure 12. Wet Age-Related Macular Degeneration Treatment Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030) & (K Units)
    Figure 15. World Wet Age-Related Macular Degeneration Treatment Consumption Market Share by Region (2019-2030)
    Figure 16. United States Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030) & (K Units)
    Figure 17. China Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030) & (K Units)
    Figure 18. Europe Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030) & (K Units)
    Figure 19. Japan Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030) & (K Units)
    Figure 22. India Wet Age-Related Macular Degeneration Treatment Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Wet Age-Related Macular Degeneration Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Wet Age-Related Macular Degeneration Treatment Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Wet Age-Related Macular Degeneration Treatment Markets in 2023
    Figure 26. United States VS China: Wet Age-Related Macular Degeneration Treatment Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Wet Age-Related Macular Degeneration Treatment Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Wet Age-Related Macular Degeneration Treatment Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Market Share 2023
    Figure 30. China Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Wet Age-Related Macular Degeneration Treatment Production Market Share 2023
    Figure 32. World Wet Age-Related Macular Degeneration Treatment Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Wet Age-Related Macular Degeneration Treatment Production Value Market Share by Type in 2023
    Figure 34. Lucentis
    Figure 35. Eylea
    Figure 36. Avastin
    Figure 37. Others
    Figure 38. World Wet Age-Related Macular Degeneration Treatment Production Market Share by Type (2019-2030)
    Figure 39. World Wet Age-Related Macular Degeneration Treatment Production Value Market Share by Type (2019-2030)
    Figure 40. World Wet Age-Related Macular Degeneration Treatment Average Price by Type (2019-2030) & (US$/Unit)
    Figure 41. World Wet Age-Related Macular Degeneration Treatment Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 42. World Wet Age-Related Macular Degeneration Treatment Production Value Market Share by Application in 2023
    Figure 43. Hospital
    Figure 44. Clinic
    Figure 45. Other
    Figure 46. World Wet Age-Related Macular Degeneration Treatment Production Market Share by Application (2019-2030)
    Figure 47. World Wet Age-Related Macular Degeneration Treatment Production Value Market Share by Application (2019-2030)
    Figure 48. World Wet Age-Related Macular Degeneration Treatment Average Price by Application (2019-2030) & (US$/Unit)
    Figure 49. Wet Age-Related Macular Degeneration Treatment Industry Chain
    Figure 50. Wet Age-Related Macular Degeneration Treatment Procurement Model
    Figure 51. Wet Age-Related Macular Degeneration Treatment Sales Model
    Figure 52. Wet Age-Related Macular Degeneration Treatment Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Companies Mentioned

Roche
Novartis
Regeneron Pharmaceuticals
Bayer HealthCare
Kanghong Pharma